Biomarker Strategies Logo


Homepage

 

 



Investors

BioMarker Strategies is a privately held, Maryland-based limited-liability company located in Rockville, Maryland. To date, the company has been funded by private investors, including the Abell Foundation. BioMarker Strategies has also been awarded approximately $5m in non-dilutive funding from the National Cancer Institute to develop the SnapPath® platform, including a recent $1.5m Phase II SBIR award to develop a predictive diagnostic test for advanced melanoma patients.

For more information about investment opportunities at the company, please contact Jerry Parrott at jparrott@biomarkerstrategies.com

 

 


© 2014 BioMarker Strategies